|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 19/11 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 453K 427K 388K 727K 49.8M 730K 5.12M 1.98M 25.32M 1.95M 1.91M 81.47M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.23M 18.15M 16.49M 30.89M 2.12B 31.02M 217M 83.92M 1.08B 82.83M 80.99M 3.46B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.20% | +3.26% | +26.15% | +45.30% | 400.19B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.15% | +61.76% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.42M 1.34M 1.22M 2.28M 156M 2.29M 16.05M 6.19M 79.37M 6.11M 5.98M 255M | 2.38M 2.08M 1.96M 1.78M 3.34M 229M 3.35M 23.52M 9.08M 116M 8.96M 8.76M 374M |
| Net income | -9.14M -7.97M -7.53M -6.84M -12.81M -877M -12.86M -90.17M -34.8M -446M -34.34M -33.58M -1.44B | -8.02M -6.99M -6.6M -5.99M -11.23M -769M -11.28M -79.05M -30.51M -391M -30.11M -29.44M -1.26B |
| Net Debt | 17.85M 15.57M 14.7M 13.35M 25.01M 1.71B 25.11M 176M 67.95M 871M 67.07M 65.58M 2.8B | 21.53M 18.77M 17.73M 16.1M 30.16M 2.07B 30.29M 212M 81.94M 1.05B 80.88M 79.08M 3.38B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
